Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG Block vs LP Block for Postoperative Analgesia in Anterior THA
NCT05261009Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jun 2022
- Primary completion
- Jul 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain, sponsored by Wake Forest University Health Sciences. Primary endpoint: Numeric Rating Scale at 6 hours. Started Jun 2022; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05261009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05261009.